Everolimus enhances cellular cytotoxicity of lapatinib via the eukaryotic elongation factor-2 kinase pathway in nasopharyngeal carcinoma cells

nork Liu, Lin, Wang, Zhi-Hui, Han, Jun, Tang, Con, Chen, Nan, Lin, Zhong, Peng, Pei-Jian
Argitaratua izan da Onco Targets Ther (2016)

Inhibition of eEF-2 kinase sensitizes human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways

nork Liu, Lin, Huang, PeiYu, Wang, ZhiHui, Chen, Nan, Tang, Con, Lin, Zhong, Peng, PeiJian
Argitaratua izan da BMC Cancer (2016)

Phase II study of gemcitabine plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy

nork Peng, PeiJian, Ou, XueQing, Liao, Hai, Liu, YuMeng, Wang, SiYang, Cheng, ZhiBin, Lin, Zhong
Argitaratua izan da Ther Adv Med Oncol (2016)

Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimen...

nork Peng, Pei-Jian, Lv, Bao-Jun, Wang, Zhi-Hui, Liao, Hai, Liu, Yu-Meng, Lin, Zhong, Con, Yun-Yan, Huang, Pei-Yu
Argitaratua izan da Ther Adv Med Oncol (2016)

Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma

nork Lin, Zhong, Lv, Wei-Ze, Wang, Si-Yang, Zou, Jin-Lin, Con, Yun-Yan, Wang, Zhi-Hui, Xiao, Mei, Peng, Pei-Jian
Argitaratua izan da Cancer Manag Res (2017)

Dose Escalation of Lobaplatin Concurrent with IMRT for the Treatment of Stage III-IVb NPC: A Phase I Clinical Trial()()

nork Wang, Si-Yang, Xu, Xi-Wei, Yao, Ji-Jin, Peng, Pei-Jian, Zhou, Bin, Liu, Qiao-Dan, Huang, Xiao-Ping, Lin, Zhong
Argitaratua izan da Transl Oncol (2018)

Phase II Study of a Bi-Weekly Chemotherapy Regimen of Combined Liposomal Paclitaxel and Nedaplatin for the Treatment of Advanced Squamous Cell Lung Cancer

nork Lv, Wei-Ze, Lin, Zhong, Wang, Si-Yang, Lv, Bao-Jun, Wang, Zhi-Hui, Xiao, Mei, Xu, Xiao-Lu, Peng, Pei-Jian
Argitaratua izan da Transl Oncol (2019)

Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma

nork Peng, Pei-Jian, Lv, Bao-Jun, Tang, Con, Liao, Hai, Lin, Zhong, Liu, Yu-Meng, Wang, Zhi-Hui, Wang, Si-Yang, Cheng, Zhi-Bin
Argitaratua izan da Drug Des Devel Ther (2015)

CD47 Overexpression Is Associated with Epstein–Barr Virus Infection and Poor Prognosis in Patients with Nasopharyngeal Carcinoma

nork Wang, Zhi-Hui, Pei, Xiao-Feng, Zhu, Zhi-Quan, Lin, Zhong, Mao, Yin-Yan, Xu, Xiao-Lu, Luo, You-Li, Zhang, Li, Peng, Pei-Jian
Argitaratua izan da Onco Targets Ther (2020)

Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospectiv...

nork Peng, Pei-Jian, Cheng, Hua, Ou, Xue-Qing, Zeng, Lin-Juan, Wu, Xuan, Liu, Yu-Meng, Lin, Zhong, Tang, Yan-Na, Wang, Si-Yang, Zhang, Hong-Yu, Chen, Zhi-Bin
Argitaratua 2014